Regeneron Pharmaceuticals - M&A Summary and Business Overview

Life ScienceCompany

Regeneron Pharmaceuticals M&A Summary

Regeneron Pharmaceuticals has acquired 2 companies, including 2 in the last 5 years. A total of 1 acquisition came from private equity firms.

Regeneron Pharmaceuticals’ largest acquisition to date was in 2022, when it acquired Checkmate Pharmaceuticals for $250M. Regeneron Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Regeneron Pharmaceuticals Business Overview

Where is Regeneron Pharmaceuticals headquartered?

Regeneron Pharmaceuticals is headquartered in Tarrytown, New York.

What is Regeneron Pharmaceuticals’ revenue?

Regeneron Pharmaceuticals disclosed revenue of 13,117M USD for 2023 and 12,173M USD for 2022.

How many employees does Regeneron Pharmaceuticals have?

Regeneron Pharmaceuticals has 13,677 employees.

What sector is Regeneron Pharmaceuticals in?

Regeneron Pharmaceuticals is a life science company.

When was Regeneron Pharmaceuticals founded?

Regeneron Pharmaceuticals was founded in 1988.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 1

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road,
Tarrytown, New York 10591
United States,
(914) 347-7000
www.regeneron.com

Regeneron Pharmaceuticals is a biopharmaceutical company based that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition, and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. Regeneron Pharmaceuticals was founded in 1988 and is based in Tarrytown, New York.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - - - 1 1 - 2
vol $250M $109M $359M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Decibel Therapeutics, Inc. 2023-08-09 109M USD Merger
Boston, Massachusetts · www.decibeltx.com
Checkmate Pharmaceuticals, Inc. 2022-04-19 250M USD Add-on Acquisition
Cambridge, Massachusetts · www.checkmatepharma.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 359M (100%) - -
Total 2 $359M - -

By Geo

State/Country Buy Value Sell Value
United States 2 359M - -
  Massachusetts 2 359M - -
Total 2 $359M - -

Top M&A Advisors

Legal Deals
Wachtell, Lipton, Rosen & Katz
 2

Deal Values

buy # Total
$100M to $1B 2 $359M
TOTAL $359M
Largest Checkmate Pharmaceuticals, Inc.
$250M (2022-04-19)

M&A Connections

Deals
Acquired from
Investor(s)
50%
1 (50%)

Company Summary

SECTOR

Life Science

Revenue

13,117   8% 2023
12,173   25% 2022
16,072   90% 2021
8,497   9% 2020
7,863   18% 2019
6,711   15% 2018
5,872   21% 2017
4,860   19% 2016
4,104   46% 2015
2,820   35% 2014
2,104   53% 2013
1,378   2012
(millions of USD) Show More Show Less

Employees

13,677

Established

1988

Public

NASDAQ: REGN

 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Regeneron Pharmaceuticals

New York Companies , Life Science Companies , United States Companies , New York Life Science Companies , New York Life Science with Acquisitions , New York Life Science with Divestitures

Related Lists for New York Companies

Largest New York Companies , Acquisitive New York Companies , Recently Acquired New York Companies , Recently Sold New York Companies , Private New York Companies , Public New York Companies , Acquired New York Companies , PE Backed New York Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal